- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings
Patent holdings for IPC class A61K 31/4709
Total number of patents in this class: 5444
10-year publication summary
|
384
|
401
|
368
|
444
|
437
|
423
|
430
|
373
|
347
|
200
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 690 |
83 |
| Janssen Pharmaceutica N.V. | 3423 |
61 |
| Centre National de La Recherche Scientifique | 10321 |
60 |
| Bristol-myers Squibb Company | 4892 |
54 |
| The Regents of the University of California | 19812 |
51 |
| Boehringer Ingelheim International GmbH | 4704 |
51 |
| Arog Pharmaceuticals, Inc. | 51 |
47 |
| Vertex Pharmaceuticals Incorporated | 1596 |
46 |
| F. Hoffmann-La Roche AG | 7926 |
45 |
| Gilead Sciences, Inc. | 2028 |
44 |
| Novartis AG | 10904 |
39 |
| Institut Curie | 575 |
39 |
| Universite de Montpellier | 976 |
38 |
| Kura Oncology, Inc. | 110 |
37 |
| Merck Sharp & Dohme LLC | 3741 |
37 |
| Abivax | 119 |
36 |
| Merck Patent GmbH | 5850 |
35 |
| Amgen Inc. | 4047 |
34 |
| Taisho Pharmaceutical Co., Ltd. | 862 |
33 |
| AstraZeneca AB | 2928 |
31 |
| Other owners | 4543 |